Friday, January 27, 2023

Tag: NIH

How a Flood of Corporate Funding Can Distort NIH Research

0
From The Washington Post: "At the heart of the matter is money. As Congress has declined to spend more on research, many academics have been...

Why Slashing the NIH Budget is Indefensible

0
In this op-ed for The Washington Post, Katrina vanden Heuvel critiques President Trump's plan to cut funding for the National Institutes of Health (NIH) by...

“What Will President Trump Mean for Science?

1
Sarah Kaplan for the Washington Post reports that while “Trump has pledged to cut federal spending he hasn’t offered details on how this will affect funding for scientific research.”

“NIH Awards $150 million for Research on Environmental Influences on Child...

1
The National Institutes of Health announced $157 million in awards in fiscal year 2016 to launch a seven-year initiative called Environmental influences on Child...

NIH Hospital Made Patient Safety ‘Subservient to Research’

1
A Washington-Post exclusive reveals that that the leadership of the flagship hospital of the National Institute of Health (NIH) is being restructured after a...

“NIH-Funded Trials Dip, Industry Trials on the Rise”

0
"Every year since 2006 in the U.S., the amount of new medical research in humans that’s funded by the National Institutes of Health (NIH) has gone down, while the number of industry-funded trials has gone up, a new study shows.”

NIMH Funding Changes Threaten Psychotherapy Research

8
The National Institute of Mental Health (NIMH) is increasingly shifting its research emphasis toward attempting to uncover biomarkers for “mental diseases,” which may have dramatic consequences for research and training in clinical psychology. In an article to be published in next month’s Professional Psychology: Research and Practice, Marvin Goldfried outlines how the shift in funding priorities for psychological research is tied to the needs of pharmaceutical companies and the biological model in psychiatry.

Landmark Schizophrenia Study Recommends More Therapy

50
Results of a large government-funded study call into question current drug heavy approaches to treating people diagnosed with schizophrenia. The study, which the New York Times called “by far the most rigorous trial to date conducted in the United States,” found that patients who received smaller doses of antipsychotic drugs with individual talk therapy, family training, and support for employment and education had a greater reduction in symptoms as well as increases in quality of life, and participation in work and school than those receiving the current standard of care.

How You and I Can Take Back Translational Medicine – THIS...

10
I've been hearing about translational medicine for a long time and wondering what it was. For the most part, it's a huge subsidy to...